Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One Click COPY FOR FREE
Biotricity announces common stock and warrant offering
Editor
Published Feb 29, 2024 01:24
© Reuters.
In a recent SEC filing, Biotricity Inc (NASDAQ: BTCY), a healthcare technology company, has disclosed its plans to offer shares of common stock and pre-funded warrants. The company is set to sell these securities on a best-efforts basis, with the number of shares and the offering price per share yet to be determined.
The offering price assumes a value equal to the last sale price of Biotricity's common stock as reported by The Nasdaq Capital Market on a specified date in February 2024.
This strategic move also includes an option for purchasers who, as a result of the offering, would own more than 4.99% of the outstanding common stock. These purchasers can elect to buy pre-funded warrants instead, which would prevent their ownership from exceeding either 4.99% or 9.99%, based on their preference.
The pre-funded warrants are immediately exercisable for one share of common stock at a nominal exercise price of $0.0001 each and can be exercised at any time until they are fully exercised.
The cost of each pre-funded warrant will be the public offering price of the common stock minus $0.0001. Importantly, the availability of common stock is adjusted on a one-for-one basis for each pre-funded warrant sold. Moreover, the prospectus includes the common stock that may be issued upon the exercise of the pre-funded warrants sold in this offering.
The filing indicates that Biotricity is aiming to increase its financial flexibility and raise capital, although the specific use of the proceeds from this offering was not detailed in the SEC filing. The exact date of the offering and the number of securities to be sold will be established at a future time.
Investors and market observers are keeping a close eye on the company's activities, as these types of offerings can have implications for the company's stock performance and capital structure. The information regarding this offering is based on the press release statement filed with the SEC.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.